278 related articles for article (PubMed ID: 33982196)
1. Role of cardiovascular magnetic resonance in early detection and treatment of cardiac dysfunction in oncology patients.
Vallabhaneni S; Zhang KW; Alvarez-Cardona JA; Mitchell JD; Steen H; Woodard PK; Lenihan DJ
Int J Cardiovasc Imaging; 2021 Oct; 37(10):3003-3017. PubMed ID: 33982196
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of cardiac magnetic resonance for early detection of cancer therapeutics-related cardiac dysfunction in breast cancer patients.
Terui Y; Sugimura K; Ota H; Tada H; Nochioka K; Sato H; Katsuta Y; Fujiwara J; Harada-Shoji N; Sato-Tadano A; Morita Y; Sun W; Higuchi S; Tatebe S; Fukui S; Miyamichi-Yamamoto S; Suzuki H; Yaoita N; Kikuchi N; Sakota M; Miyata S; Sakata Y; Ishida T; Takase K; Yasuda S; Shimokawa H
Int J Cardiol; 2023 Jan; 371():472-479. PubMed ID: 36115441
[TBL] [Abstract][Full Text] [Related]
3. Can Quantitative CMR Tissue Characterization Adequately Identify Cardiotoxicity During Chemotherapy?: Impact of Temporal and Observer Variability.
Altaha MA; Nolan M; Marwick TH; Somerset E; Houbois C; Amir E; Yip P; Connelly KA; Michalowska M; Sussman MS; Wintersperger BJ; Thavendiranathan P
JACC Cardiovasc Imaging; 2020 Apr; 13(4):951-962. PubMed ID: 31864977
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction.
Narayan HK; French B; Khan AM; Plappert T; Hyman D; Bajulaiye A; Domchek S; DeMichele A; Clark A; Matro J; Bradbury A; Fox K; Carver JR; Ky B
JACC Cardiovasc Imaging; 2016 Oct; 9(10):1131-1141. PubMed ID: 27085442
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of Cardiac Computed Tomography in the Diagnosis of Anti-Cancer Therapy-Related Cardiac Dysfunction - Consistency With Magnetic Resonance Imaging.
Sueta D; Kidoh M; Oda S; Egashira K; Yamamoto E; Kaikita K; Matsushita K; Yamamoto Y; Hirai T; Tsujita K
Circ J; 2021 Mar; 85(4):393-396. PubMed ID: 33597324
[TBL] [Abstract][Full Text] [Related]
6. Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer: Comparison With Echocardiography.
Houbois CP; Nolan M; Somerset E; Shalmon T; Esmaeilzadeh M; Lamacie MM; Amir E; Brezden-Masley C; Koch CA; Thevakumaran Y; Yan AT; Marwick TH; Wintersperger BJ; Thavendiranathan P
JACC Cardiovasc Imaging; 2021 May; 14(5):962-974. PubMed ID: 33248962
[TBL] [Abstract][Full Text] [Related]
7. The association of reduced global longitudinal strain with cancer therapy-related cardiac dysfunction among patients receiving cancer therapy.
Laufer-Perl M; Arnold JH; Mor L; Amrami N; Derakhshesh M; Moshkovits Y; Sadeh B; Arbel Y; Topilsky Y; Rozenbaum Z
Clin Res Cardiol; 2020 Feb; 109(2):255-262. PubMed ID: 31214777
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Imaging in Cardio-oncology.
Tong D; Zaha VG
J Cardiovasc Transl Res; 2020 Jun; 13(3):357-366. PubMed ID: 31696405
[TBL] [Abstract][Full Text] [Related]
9. Machine Learning-Based Risk Assessment for Cancer Therapy-Related Cardiac Dysfunction in 4300 Longitudinal Oncology Patients.
Zhou Y; Hou Y; Hussain M; Brown SA; Budd T; Tang WHW; Abraham J; Xu B; Shah C; Moudgil R; Popovic Z; Cho L; Kanj M; Watson C; Griffin B; Chung MK; Kapadia S; Svensson L; Collier P; Cheng F
J Am Heart Assoc; 2020 Dec; 9(23):e019628. PubMed ID: 33241727
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of Echocardiographic Techniques to Detect Subclinical Cancer Therapeutics-Related Cardiac Dysfunction among High-Dose Patients When Compared with Cardiac Magnetic Resonance Imaging.
Toro-Salazar OH; Ferranti J; Lorenzoni R; Walling S; Mazur W; Raman SV; Davey BT; Gillan E; O'Loughlin M; Klas B; Hor KN
J Am Soc Echocardiogr; 2016 Feb; 29(2):119-31. PubMed ID: 26678319
[TBL] [Abstract][Full Text] [Related]
11. Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction.
Demissei BG; Hubbard RA; Zhang L; Smith AM; Sheline K; McDonald C; Narayan V; Domchek SM; DeMichele A; Shah P; Clark AS; Fox K; Matro J; Bradbury AR; Knollman H; Getz KD; Armenian SH; Januzzi JL; Tang WHW; Liu P; Ky B
J Am Heart Assoc; 2020 Jan; 9(2):e014708. PubMed ID: 31959034
[TBL] [Abstract][Full Text] [Related]
12. Role of cardiovascular magnetic resonance imaging in cardio-oncology.
Saunderson CED; Plein S; Manisty CH
Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):383-396. PubMed ID: 33404058
[TBL] [Abstract][Full Text] [Related]
13. Rationale and Design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes: The SUCCOUR Trial.
Negishi T; Thavendiranathan P; Negishi K; Marwick TH;
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1098-1105. PubMed ID: 29909105
[TBL] [Abstract][Full Text] [Related]
14. Cardio-oncology: the role of advanced echocardiography in cancer patients.
Venneri L; Zoppellaro G; Khattar RS
Expert Rev Cardiovasc Ther; 2018 Apr; 16(4):249-258. PubMed ID: 29457984
[TBL] [Abstract][Full Text] [Related]
15. The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patients.
Lapirow D; La Gerche A; Toro C; Masango E; Costello B; Porello E; Ludlow L; Marshall G; Trahair T; Mateos M; Lewin J; Byrne J; Boutros R; Manudhane R; Heath J; Ayer J; Gabriel M; Walwyn T; Saundankar J; Forsey J; Le H; Mason K; Celermajer D; Downie P; Walker R; Holland L; Martin M; McLeman L; Diamond Y; Marcocci M; Donath S; Cheung M; Elliott DA; Conyers R
Intern Med J; 2021 Feb; 51(2):229-234. PubMed ID: 31841257
[TBL] [Abstract][Full Text] [Related]
16. MRI of Cardiotoxicity.
Jordan JH; Hundley WG
Cardiol Clin; 2019 Nov; 37(4):429-439. PubMed ID: 31587784
[TBL] [Abstract][Full Text] [Related]
17. Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies.
Biersmith MA; Tong MS; Guha A; Simonetti OP; Addison D
J Am Heart Assoc; 2020 Jan; 9(2):e013755. PubMed ID: 31960741
[No Abstract] [Full Text] [Related]
18. Cardiovascular Magnetic Resonance in the Oncology Patient.
Jordan JH; Todd RM; Vasu S; Hundley WG
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1150-1172. PubMed ID: 30092971
[TBL] [Abstract][Full Text] [Related]
19. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
Čelutkienė J; Pudil R; López-Fernández T; Grapsa J; Nihoyannopoulos P; Bergler-Klein J; Cohen-Solal A; Farmakis D; Tocchetti CG; von Haehling S; Barberis V; Flachskampf FA; Čeponienė I; Haegler-Laube E; Suter T; Lapinskas T; Prasad S; de Boer RA; Wechalekar K; Anker MS; Iakobishvili Z; Bucciarelli-Ducci C; Schulz-Menger J; Cosyns B; Gaemperli O; Belenkov Y; Hulot JS; Galderisi M; Lancellotti P; Bax J; Marwick TH; Chioncel O; Jaarsma T; Mullens W; Piepoli M; Thum T; Heymans S; Mueller C; Moura B; Ruschitzka F; Zamorano JL; Rosano G; Coats AJS; Asteggiano R; Seferovic P; Edvardsen T; Lyon AR
Eur J Heart Fail; 2020 Sep; 22(9):1504-1524. PubMed ID: 32621569
[TBL] [Abstract][Full Text] [Related]
20. Right ventricle toxicity in cancer treatment: a focused review on cardiac imaging.
Sanadgol G; Samimi S; Shirini D; Nakhaei P; Mohseni M; Alizadehasl A
Future Cardiol; 2023 Sep; 19(11):537-545. PubMed ID: 37830360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
